More on fluvoxamine and enuresis.
Kano
K
K
Arisaka
O
O
D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D016022:Case-Control Studies; D002648:Child; D018592:Cross-Over Studies; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D004775:Enuresis / Q000188:drug therapy*; D005260:Female; D016666:Fluvoxamine / Q000627:therapeutic use*; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D012076:Renal Agents / Q000627:therapeutic use; D016896:Treatment Outcome
D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D012076:Renal Agents; D003894:Deamino Arginine Vasopressin; D016666:Fluvoxamine; D007099:Imipramine